MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: Diagnostic and prognostic implications

American Journal of Surgical Pathology

Volumn 29, Issue 7, 2005, Pages 881-889

  Handra Luca, Adriana ^a   Lamas, Georges ^b   Bertrand, Jacques Charles ^b   Fouret, Pierre ^b,c  

^a UNIVERSITÉ PARIS 13   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Diagnosis; Immunohistochemistry; Mucin; Mucoepidermoid; Prognosis

Indexed keywords

ALCIAN BLUE; MUCIN 1; MUCIN 2; MUCIN 4; MUCIN 5AC;

ADENOSQUAMOUS CARCINOMA; ADULT; APICAL MEMBRANE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CELL LABELING; CELL TYPE; CLINICAL FEATURE; CYTOPLASM; EPIDERMOID TUMOR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MICROSCOPE; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; TUMOR CELL;

CARCINOMA, MUCOEPIDERMOID; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCINS; PROGNOSIS; SALIVARY GLAND NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 21244456907     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000159103.95360.e8     Document Type: Article

References (31)

1. Alos L, Lujan B, Castillo M, et al. Expression of mucins (MUC1, MUC2, MUC5AC, MUC6) in mucoepidermoid carcinomas of salivary glands [Abstract]. Mod Pathol. 2004;17:926.
2. Awaya H, Takeshima Y, Yamasaki M, et al. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung. Am J Clin Pathol. 2004; 121:644-653.
3. Baldus SE, Monig SP, Hanisch FG, et al. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma. Histopathology. 2002;40:440-449.
4. Bootz F, Hermanek P, Howaldt H, et al. TNM Atlas. Paris: Springer-Verlag; 1998:5-69.
5. Brandwein MS, Ivanov K, Wallace DI, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001;25:835-845.
6. Chu PG, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol. 2004; 121:884-892.
7. Dardick I, Gliniecki MR, Heathcote JG, et al. Comparative histogenesis and morphogenesis of mucoepidermoid carcinoma and pleomorphic adenoma: an ultrastructural study. Virchows Arch A Pathol Anat Histopathol. 1990;417:405-417.
8. Dekker J, Rossen JW, Buller HA, et al. The MUC family: an obituary. Trends Biochem Sci. 2002;27:126-131.
9. Dong Y, Walsh MD, Cummings MC, et al. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumors. J Pathol. 1997;183:311-317.
10. Ellis G, Auclair P. Tumors of the salivary glands. In: Rosai J, Sobin L eds. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology, 1996:155-373.
11. Fonseca I, Costa Rosa J, Felix A, et al. Simple mucin-type carbohydrate antigens (T, Tn and sialosyl-Tn) in mucoepidermoid carcinoma of the salivary glands. Histopathology. 1994;25:537-543.
12. Guddo F, Giatromanolaki A, Koukourakis MI, et al. MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients. J Clin Pathol. 1998;51:667-671.
13. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2004;4:45-60.
14. Kufe D, Inghirami G, Abe M, et al. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma. 1984;3:223-232.
15. Lee HS, Lee HK, Kim HS, et al. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer. 2001;92:1427-1434.
16. Lee HS, Chang MS, Yang HK, et al. Epstein-Barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein-Barr virus-negative carcinoma. Clin Cancer Res. 2004;10:1698-1705.
17. Li Y, Liu D, Chen D, et al. Human DF3/MUC1 carcinoma-associated protein functions as an oncogens. Oncogene. 2003;22:6107-6110.
18. Mannweiler S, Beham A, Langner C. MUC1 and MUC2 expression in salivary gland tumors and in non-neoplastic salivary gland tissue. APMIS. 2003;111:978-984.
19. McGuckin MA, Walsh MD, Hohn BG, et al. Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum Pathol. 1995; 26:432-439.
20. Nikitakis NG, Tosios KI, Papanikolaou VS, et al. Immunohistochemical expression of cytokeratins 7 and 20 in malignant salivary gland tumors. Mod Pathol. 2004;17:407-415.
21. Nishiumi N, Abe Y, Inoue Y, et al. Use of 11p15 mucins as prognostic factors in small adenocarcinoma of the lung. Clin Cancer Res. 2003;9: 5616-5619.
22. Price MR, Rye PD, Petrakou E, et al. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. Tumour Biol 1998;19:1-20.
23. Reis CA, David L, Nielsen PA, et al. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer. 1997;74:112-121.
24. Roa RA, Hruban RH, McKenzie P, et al. Tumor-associated glycoprotein expression in salivary gland mucoepidermoid carcinomas: an immunohistochemical study using the monoclonal antibody B72.3. Laryngoscope. 1994;104:304-308.
25. Rossi EA, McNeer RR, Price-Schiavi SA, et al. Sialomucin complex, a heterodimeric glycoprotein complex: expression as a soluble, secretable form in lactating mammary gland and colon. J Biol Chem. 1996;271: 33476-33485.
26. Rossi G, Murer B, Cavazza A, et al. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression. Am J Surg Pathol. 2004;28:442-452.
27. Scholl SM, Balloul JM, Le Goc G, et al. Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer. J Immunother. 2000;23:570-580.
28. Sessions R, Harrisson L, Forastiere A. Tumors of the salivary glands and paragangliomas. In: DeVita V, Rosenberg S, eds. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins. 2000: 886-900.
29. Sivridis E, Giatromanolaki A, Koukourakis MI, et al. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance. Histopathology. 2002;40:92-100.
30. Weed DT, Gomez-Fernandez C, Pacheco J, et al. MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma. Head Neck. 2004;26:353-364.
31. Xing PX, Prenzoska J, Layton GT. et al. Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer. J Natl Cancer Inst. 1992;84:699-703.